CXCL8 and breast neoplasm: Ginestier and colleagues [91] also showed that blocking of both the receptors for IL8, CXCR1, and CXCR2, by treatment with the drug repertaxin, significantly reduced the formation of bone metastasis after intracardiac injection of breast tumor cells in mice.